Calcium antagonists in the treatment of hypertension.

Hypertension ◽  
1983 ◽  
Vol 5 (4_pt_2) ◽  
1993 ◽  
Vol 6 (3_Pt_2) ◽  
pp. 98S-101S ◽  
Author(s):  
N. Fetkovska ◽  
Z. Jakubovska ◽  
J. Oravcova ◽  
P. Tison ◽  
L. Ulicna ◽  
...  

1991 ◽  
Vol 29 (6) ◽  
pp. 21-22

Alpha-adrenergic blockers, calcium antagonists and some angiotensin-converting enzyme (ACE) inhibitors are now promoted as first-line drugs for the treatment of hypertension, competing with the traditional choices of β-adrenergic blockers and diuretics. The older drugs have established long-term benefits, but have some theoretical disadvantages and sometimes unwanted effects. No trials have looked at the impact of these new drugs on cardiovascular disease; studies of their efficacy have examined only immediate outcome measures such as blood pressure, and their effects on other risk factors for arterial disease such as plasma lipids. Choosing a drug for the initial treatment of hypertension has therefore become more difficult. We discuss here a new α-blocker and three recently marketed calcium antagonists.


1988 ◽  
Vol 12 (Supplement 6) ◽  
pp. S104-S108 ◽  
Author(s):  
Björn Dahlöf ◽  
Robert Eggertsen ◽  
Lennart Hansson

1984 ◽  
Vol 77 (4) ◽  
pp. 26-30 ◽  
Author(s):  
Cornelis Van Breemen ◽  
Scott Lukeman ◽  
Cynthia Cauvin

CHEST Journal ◽  
1988 ◽  
Vol 93 (6) ◽  
pp. 1251-1253 ◽  
Author(s):  
C. Venkata S. Ram ◽  
William E. Featherston

1987 ◽  
Vol 10 ◽  
pp. S136-137 ◽  
Author(s):  
L. Aldo Ferrara ◽  
Fabrizio Pasanisi ◽  
Teodoro Marotta ◽  
Paolo Rubba ◽  
Mario Mancini

Sign in / Sign up

Export Citation Format

Share Document